DISCOVER xM: NEW PORTFOLIO OF MRD & MONITORING ASSAYS /// LEARN MORE DISCOVER xM: NEW PORTFOLIO OF MRD & MONITORING ASSAYS /// LEARN MORE
Hero Background

Multi-omics

High-throughput solutions delivering comprehensive datasets for a critical, integrated, and holistic understanding of your population

Tempus offers a broad range of technologies to support research and development, including genotyping, methylation, NGS, and proteomics.

Genotyping

Our wide portfolio of genotyping solutions fit the needs of small and high volume data projects:

Illumina

  • Medium to high throughput volumes
  • Multiple arrays for GWAS sample analysis
  • Arrays and boosters for a wide variety of testing, such as PGx

Thermofisher

  • Medium to high throughput volumes
  • Enables GWAS, PGx, and Gene Expression analysis
  • 24, 96 sample formats
image description

Methylation

We have robust methylation solutions with an optimized workflow for high quality data
  • Extensive experience running Illumina Infinium EPIC.v2 935k Bead Chip at a cost-effective price
  • Assay can provide data for research applications such as methylation profiling and biological age calculations
  • Supports data generation for EWAS analysis
image description

NGS

The full Illumina NGS suite of instruments, including NovaSeqX+ (est. Q1-23)

Whole Genome / Exome / Transcriptome Sequencing

  • Faster, powerful Whole Genome sequencing at an affordable price (30x-200x)
  • Cost-effective Low Pass WGS, with or without imputation, delivering large data quantities
  • Whole exome and whole transcriptome sequencing with flexible coverage

Metagenomics

  • Supports microbiome analysis through shotgun  or 16s rRNA sequencing  
  • 16S rRNA sequencing analyzes the prokaryotic 16S ribosomal RNA gene (1500 bp), which contains 9 variable regions (species-specific)
  • Excellent resource for gut microbiome monitoring or ongoing research
image description

PROTEOMICS

Explore the proteome with our Olink and SomaLogic platforms*, designed for advanced biomarker discovery and multi-omic analysis. These technologies excel in measuring protein concentrations across various sample types, including plasma, serum, and more.

Olink Explore 3072

  • Quantify ~2,400 protein targets
  • Designed for high-throughput biomarker discovery
  • Optimal for exploratory proteomics and multi-omic studies
  • Access eight targeted 384-plex panels for disease-specific and biological process research**

Olink Explore HT

  • Measure ~5,400 protein targets
  • Achieve high specificity with minimal sample requirements
  • Equipped with user-friendly data tools, suitable for all project sizes
  • Employ a single-panel approach for efficient high-throughput analysis and a streamlined workflow

Coming in 2024: SomaLogic SomaScan

  • Asses ~6,000 protein targets
  • Utilize high-plex, high-throughput technology for extensive research
  • Gain access to a comprehensive dataset for in-depth proteomic biomarker analysis
  • Perform simultaneous measurements of thousands of proteins from a single panel
image description

Our differentiators

  • Strong partnership

    and collaboration to find custom solutions for successful outcomes

  • High quality data

    from automated workflows across Multi-omic platforms

  • Fast turnaround time

    on average 10 days from batch creation

  • Wide range of technology

    With US-based labs, including processing and customer support

image description
Our Impact

It is great to have a familiar genomic service provider in Atlanta. [Tempus Multi-omics] brings a lot of experience and has provided responsive and cost-effective methylation and gene expression profiling for us on multiple occasions.

Dr. Greg Gibson, Professor and Director, Center for Integrative Genomics, Georgia Institute of Technology

Our Impact

The UC Athena project is utilizing [Tempus Multi-omics]’s expert capability to screen for genome variants in the context of cancer.

Dr. Laura van’t Veer, Professor and Endowed Chair in Cancer Research, Department of Laboratory Medicine, UCSF

Our Impact

We were attracted to [Tempus Multi-omics] because of their outstanding quality and service oriented approach as well as their know-how in molecular genetic technologies. The unique partnership with [Tempus Multi-omics] will allow us to expand our comprehensive suite of services that have successfully supported the pharma market for nine years. Through this collaboration, we will be able to better serve all of our customers in the US, with the unmatched quality and value-added services that we have established over the past nine years.

Dr. Thomas Henkel, CEO of Targos

Our Impact

We are very pleased to be working with [Tempus Multi-omics]. They are a leading provider of genetic technologies, with advanced capabilities, including next generation forensic profiling solutions, and most importantly excellent service This combination is critical to advancing the future of forensic investigation. We have already achieved success in several of recent projects that we have completed together.

Dr. Laurence Rubin, CEO of Identitas

Our Impact

[Tempus Multi-omics] is a leader in molecular genetic technologies, and is particularly known for its outstanding delivery of service.

Don Rule, CEO of Translational Software

Product and company names are trademarks of their respective holders. Use of them does not imply affiliation or endorsement.

*Our proteomics technologies, including the advanced Olink and SomaLogic platforms, are designated for Research Use Only (RUO). They can be utilized for various research purposes, such as:

  • Retrospective analysis of clinical samples from an existing or previously closed clinical study and/or
  • Exploratory endpoint analysis within an existing clinical study or a clinical study still to be opened.

**Tailor your research with our customizable options; choose from eight specific 384-plex panels within the Explore 3072 library to focus on particular diseases and biological processes.

Partner with us

With a broad range of technologies and assays, we have the solutions you need.